Literature DB >> 7902768

Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats.

R L Stornetta1, F E Norton, P G Guyenet.   

Abstract

We sought to identify the brain areas that might contribute to the increased autonomic activity seen during morphine withdrawal by mapping neuronal expression of c-fos protein (Fos) and Fos-related antigens. Rats were implanted with morphine pellets or placebo pellets over a 5 day regimen and injected on day 6 with either saline or naltrexone (100 mg/kg). After a standard PAP immunocytochemical protocol, Fos-like immunoreactivity (Fos-LIR) was observed in medullary nuclei including the NTS (nucleus of the solitary tract), caudal (CVL) and rostral ventrolateral medulla (RVL). Although some Fos-LIR was seen in these areas in control rats (either morphine-implanted, saline injected, or placebo-implanted, saline or naltrexone injected), a significantly higher number of Fos-LIR-positive cells in NTS, CVL and RVL were seen after morphine withdrawal. Large numbers of Fos-like immunoreactive cells were also seen in the A5 area, the parabrachial nuclei of the pons and the locus coeruleus. Increased Fos-LIR was also detected in the paraventricular nucleus of the hypothalamus and the amygdala of morphine withdrawn rats. The Fos-LIR was co-localized with tyrosine hydroxylase immunoreactivity in many of the cells in caudal and rostral ventrolateral medulla, A5 and locus coeruleus. These data support the conclusion that autonomic areas in brain and noradrenergic/adrenergic cells in these areas are activated during morphine withdrawal and may contribute to the autonomic symptoms of opiate withdrawal.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902768     DOI: 10.1016/0006-8993(93)90055-r

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  24 in total

1.  Neuroadaptation of GABAergic transmission in the central amygdala during chronic morphine treatment.

Authors:  Michal Bajo; Marisa Roberto; Samuel G Madamba; George Robert Siggins
Journal:  Addict Biol       Date:  2010-12-23       Impact factor: 4.280

2.  Activation of oxytocin neurones by systemic cholecystokinin is unchanged by morphine dependence or withdrawal excitation in the rat.

Authors:  C H Brown; G Munro; N P Murphy; G Leng; J A Russell
Journal:  J Physiol       Date:  1996-11-01       Impact factor: 5.182

Review 3.  Drugs of abuse and immediate-early genes in the forebrain.

Authors:  R E Harlan; M M Garcia
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

4.  Agonist-antagonist combinations in opioid dependence: a translational approach.

Authors:  P Mannelli
Journal:  Dipend Patologiche       Date:  2010

Review 5.  Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.

Authors:  J L Scavone; R C Sterling; E J Van Bockstaele
Journal:  Neuroscience       Date:  2013-04-24       Impact factor: 3.590

6.  Local morphine withdrawal increases c-fos gene, Fos protein, and oxytocin gene expression in hypothalamic magnocellular neurosecretory cells.

Authors:  L E Johnstone; C H Brown; H K Meeren; C L Vuijst; P J Brooks; G Leng; J A Russell
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

7.  Decreases in endogenous opioid peptides in the rat medullo-coerulear pathway after chronic morphine treatment.

Authors:  E J Van Bockstaele; J Peoples; A S Menko; K McHugh; G Drolet
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

8.  Local opioid withdrawal in rat single periaqueductal gray neurons in vitro.

Authors:  B Chieng; M D Christie
Journal:  J Neurosci       Date:  1996-11-15       Impact factor: 6.167

9.  Regional Fos expression induced by morphine withdrawal in the 7-day-old rat.

Authors:  Anika A McPhie; Gordon A Barr
Journal:  Dev Psychobiol       Date:  2009-11       Impact factor: 3.038

10.  Withdrawal-induced c-Fos expression in the rat centromedial amygdala 24 h following a single morphine exposure.

Authors:  Chunyu Jin; Hiroaki Araki; Mari Nagata; Katsuya Suemaru; Kazuhiko Shibata; Hiromu Kawasaki; Takashi Hamamura; Yutaka Gomita
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.